Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force.
about
Molecular cancer prevention: Current status and future directionsUnifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screeningCervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study.Disparities in cervical cancer mortality rates as determined by the longitudinal hyperbolastic mixed-effects type II model.Acceptability and correlates of primary and secondary prevention of cervical cancer among medical students in southwest China: implications for cancer education.Changes to cervical cancer prevention guidelines: effects on screening among U.S. women ages 15-29Knowledge, perceptions, and decision making about human papillomavirus vaccination among Korean American women: a focus group study.Cervical cancer screening among young adult women in the United StatesCervical carcinoma rates among young females in the United States.Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection ratesLack of detection of human papillomavirus DNA in prostate carcinomas in patients from northeastern Brazil.Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials.Considerations in the design of randomized trials to screen for type 2 diabetes.Herpes simplex virus type 2 and the risk of cervical cancer: a meta-analysis of observational studies.Potential links between health literacy and cervical cancer screening behaviors: a systematic review.Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer.Risk evaluation for the development of cervical intraepithelial neoplasia: development and validation of risk-scoring schemes.Framing preventive care messaging and cervical cancer screening in a health-insured population in South Africa: Implications for population-based communication?Five-year survival and associated factors in women treated for cervical cancer at a reference hospital in the Brazilian Amazon.A qualitative study exploring factors associated with Pap test use among North Korean refugees.Association between FAS A670G polymorphism and susceptibility to cervical cancer: evidence from a meta-analysis.Mujer Sana, Familia Fuerte: The Effects of a Culturally-Relevant, Community-Based, <i>Promotores</i> Program to Increase Cervical Cancer Screening among Latinas.The use of conization to identify and treat severe lesions among prediagnosed CIN1 and 2 patients in Japan.
P2860
Q26797207-FAFA37CF-42CE-495A-989B-BAFF72452420Q28392615-E8DB12AA-0A3F-4D4F-889F-3A016D2876A8Q33647348-4894E7AB-3AE2-4105-8198-193FF7107501Q34203934-5326A2B8-2C1B-4216-B695-31BBFAB1BD94Q34434281-16304A63-E7A9-49BB-A6E8-B2CFC47A12E2Q35150766-034F1DF6-BFA9-4C5A-AB19-B2A722AC4598Q35164990-9E945A58-5F8E-45ED-860B-BD075C7B35AFQ35781641-2E6C1717-FA02-4B2D-B429-D247E5278524Q35966730-2868ADF3-96D7-4245-9D46-7D44BDA3E9B7Q36437417-ECDA5A6A-F63B-4EB7-B6E4-2D3CEAABEC89Q36727708-4DD403D3-817F-4AB8-BCD0-D9B7CB8E67AAQ38168499-85A06143-89BE-4CC6-82F3-EFB1A0931DB4Q38181450-FD00BD7D-DE10-49DB-A4F9-7B9D3930C254Q38230281-63EB0690-4A60-464A-8358-C0723AF5AF2EQ38530843-510E6D63-8A41-4042-92D1-FC077A7AE04BQ42215200-3A8F4C46-E88F-4BA8-89E2-058543F5645DQ42217797-19A21537-1BEE-409B-8312-F8216B30C2C4Q46404158-2F4FE97B-31B4-43BA-BF85-E6119EA90B1AQ47094443-4EC216B4-B000-437D-A3E5-10193748AE66Q47669855-DA80F7E1-AB6B-44E1-A4BD-DBAE37FA3B1EQ47896302-BF102B24-2B94-4AC8-95FD-1172DD6F08C0Q55035330-4BFB7313-9C0F-433E-9B97-9637C56438CCQ55383727-1C537F08-7426-4BDD-B22D-EF9D95433B95
P2860
Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Risk factors and other epidemi ...... reventive Services Task Force.
@en
Risk factors and other epidemi ...... reventive Services Task Force.
@nl
type
label
Risk factors and other epidemi ...... reventive Services Task Force.
@en
Risk factors and other epidemi ...... reventive Services Task Force.
@nl
prefLabel
Risk factors and other epidemi ...... reventive Services Task Force.
@en
Risk factors and other epidemi ...... reventive Services Task Force.
@nl
P2093
P1476
Risk factors and other epidemi ...... reventive Services Task Force.
@en
P2093
Brittany U Burda
Caitlyn A Senger
Evelyn P Whitlock
Kevin Lutz
Kimberly K Vesco
Michelle Eder
P304
698-705, W216
P356
10.7326/0003-4819-155-10-201111150-00377
P407
P577
2011-10-17T00:00:00Z